BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News
Concord Biotech Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
543960
ISIN Demat
INE338H01029
Book Value (Rs)
193.0629905
NSE Symbol
CONCORDBIO
Divident Yield %
0.51
Market Cap
(Rs In Cr.)
15,629
P/E (TTM)
54.96
EPS (TTM)
27.18
Face Value
(Rs)
1
Date Heading
19-Sep-26 Concord Biotech to consider bonus
18-Sep-26 Concord Biotech's Valthera unit completes US FDA audit with one proced
18-Sep-26 Indices end sideways; metal shares shine for 3rd day
31-Aug-26 Volumes spurt at Concord Biotech Ltd counter
01-Aug-26 Concord Biotech consolidated net profit rises 32.84% in the June 2026
29-Jul-26 Concord Biotech to discuss results
08-Jul-26 Concord Biotech schedules AGM
07-Jul-26 Concord Biotech fixes record date for final dividend
25-Jun-26 Concord Biotech’s formulation facility clears regulatory inspections b
25-Jun-26 Concord Biotech's Unit II formulations unit successfully clears PPB an
12-Jun-26 Concord Biotech's Limbasi unit clears Brazilian health regulatory insp
12-Jun-26 Concord Biotech completes ANVISA inspection at Limbasi API facility
10-Jun-26 Concord Biotech rallies after USFDA approval for Tofacitinib tablets
10-Jun-26 Concord Biotech receives USFDA approval for Tofacitinib Tablets
03-Jun-26 Concord Biotech gains after receiving USFDA approval for Mycophenolate
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)